TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+6.4%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$1B
AUM Growth
+$1B
(+5%)
Cap. Flow
+$6.26M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
53.49%
Holding
65
New
7
Increased
13
Reduced
12
Closed
4
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$11.1M |
| 2 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$9.83M |
| 3 |
Heron Therapeutics
HRTX
|
$9.69M |
| 4 |
Viatris
VTRS
|
$8.01M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$7.6M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$14.9M |
| 2 |
Hologic
HOLX
|
$9.94M |
| 3 |
Perrigo
PRGO
|
$8.24M |
| 4 |
iShares Biotechnology ETF
IBB
|
$8.05M |
| 5 |
Biogen
BIIB
|
$5.51M |
Sector Composition
| 1 | Healthcare | 87.13% |
| 2 | Financials | 1.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $107M | 10.66% | 1,504,712 | – | – |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $65.9M | 6.59% | 472,046 -38,000 | -7% | -$5.3M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $63.4M | 6.34% | 211,166 -49,533 | -19% | -$14.9M |
|
4
Amgen
AMGN
$155B
| $55.4M | 5.54% | 449,543 +37,400 | +9% | +$4.61M |
|
|
5
Biogen
BIIB
$19.4B
| $53.2M | 5.32% | 173,983 -18,000 | -9% | -$5.51M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $51.1M | 5.11% | 335,899 -35,430 | -10% | -$5.39M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $42.3M | 4.23% | 205,707 | – | – |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $35.3M | 3.53% | 499,764 | – | – |
|
|
9
Viatris
VTRS
$12.3B
| $31.8M | 3.18% | 652,209 +164,000 | +34% | +$8.01M |
|
10
Incyte
INCY
$16.5B
| $29.9M | 2.99% | 558,080 -30,220 | -5% | -$1.62M |
|
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $28.7M | 2.87% | 421,384 +163,143 | +63% | +$11.1M |
|
|
AGN
12
DELISTED
ALLERGAN INC
AGN
| $26.8M | 2.68% | 216,337 +49,760 | +30% | +$6.18M |
|
|
13
Perrigo
PRGO
$3.27B
| $26M | 2.6% | 167,874 -53,250 | -24% | -$8.24M |
|
|
14
iShares Biotechnology ETF
IBB
$5.6B
| $24.1M | 2.41% | 102,080 -34,026 | -25% | -$8.05M |
|
|
SHPG
15
DELISTED
Shire pic
SHPG
| $22.9M | 2.29% | 154,153 | – | – |
|
16
Puma Biotechnology
PBYI
$254M
| $19.4M | 1.93% | 185,820 | – | – |
|
|
AET
17
DELISTED
Aetna Inc
AET
| $18.5M | 1.85% | 246,841 | – | – |
|
|
CBST
18
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $16.6M | 1.66% | 226,772 | – | – |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $16.5M | 1.65% | 311,476 | – | – |
|
20
Illumina
ILMN
$15.8B
| $15.4M | 1.54% | 103,841 | – | – |
|
|
AKRX
21
DELISTED
Akorn, Inc.
AKRX
| $15.4M | 1.54% | 699,382 -236,376 | -25% | -$5.2M |
|
|
FRX
22
DELISTED
FOREST LABORATORIES INC
FRX
| $13.5M | 1.35% | 146,500 | – | – |
|
23
McKesson
MCK
$85.4B
| $12M | 1.2% | 67,862 +11,000 | +19% | +$1.94M |
|
|
CTRX
24
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $10.3M | 1.03% | 231,000 +85,000 | +58% | +$3.8M |
|
25
Verastem
VSTM
$569M
| $9.91M | 0.99% | 918,827 -100,000 | -10% | -$1.08M |
|